New CFO For Soligenix
Executive Summary
Late-stage biopharma company Soligenix Inc. has appointed Karen Krumeich senior vice president and chief financial officer (CFO), following the retirement of current acting CFO Joseph Warusz at the end of this month. Prior to joining Soligenix, Krumeich served as a consultant providing finance, investor relations and business development services to the company, before which she was vice president and CFO for several development-stage life science companies, including Cerecor Inc. and Mela Sciences Inc.